Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Atara Biotherapeutics has reported Inventory for 3 years, with the latest figure at $10.7 million in Q4 2024.

• For the quarter ending Q4 2024, Inventory rose 9.78% year-over-year to $10.7 million; the trailing twelve-month figure through Dec 2024 stood at $10.7 million (up 9.78% YoY), and the FY2024 full-year result was $10.7 million, up 9.78% from the prior year.
• Inventory for Q4 2024 stood at $10.7 million, down from $14.0 million in the prior quarter.
• The five-year high for Inventory was $18.7 million in Q2 2024, with the low at $1.6 million in Q4 2022.
• Historically, Inventory has averaged $10.1 million across 3 years, with a median of $9.7 million in 2023.
• Annual changes were most pronounced in 2023 — Inventory soared 511.98% — and 2024, when it rose 9.78%.
• Atara Biotherapeutics' Inventory stood at $1.6 million in 2022, then soared by 511.98% to $9.7 million in 2023, then gained by 9.78% to $10.7 million in 2024.
• The last three Inventory figures came in at $10.7 million (Q4 2024), $14.0 million (Q3 2024), and $18.7 million (Q2 2024), per Business Quant data.